Tyrphostin AG 126 inhibits development of postoperative ileus induced by surgical manipulation of murine colon

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 286, Issue 2 49-2, 2004, Pages

  Moore, Beverley A ^a   Türler, Andreas ^a   Pezzone, Michael A ^a   Dyer, Kevin ^a   Grandis, Jennifer ^a   Bauer, Anthony J ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Interleukin 1 ; Macrophage; Monocyte chemoattractant protein 1; Protein tyrosine kinase; Smooth muscle

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR; TYRPHOSTIN; TYRPHOSTIN AG 126; UNCLASSIFIED DRUG;

ABDOMINAL SURGERY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; COLON MUCOSA; CONTROLLED STUDY; GASTROINTESTINAL MOTILITY; GENE EXPRESSION REGULATION; ILEUS; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; INTESTINE FUNCTION; MEDIATOR RELEASE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTILITY;

EID: 1642539148     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00312.2003     Document Type: Article

References (44)

1. Adams JL and Czuprynski CJ. Mycobacterial cell wall components induce the production of TNF-α, IL-1, and IL-6 by bovine monocytes and the murine macrophage cell line RAW 264.7. Microb Pathog 16: 401-411, 1994.
2. Akira S. IL-6-regulated transcription factors. Int J Biochem Cell Biol 29: 1401-1418, 1997.
3. Ben-Bassat H. Biological activity of tyrosine kinase inhibitors: novel agents for psoriasis therapy. Curr Opin Investig Drugs 2: 1539-1545, 2001.
4. Chen CC, Chen JJ, and Chou CY. Protein kinase C-α but not p44/42 mitogen-activated protein kinase, p38, or c-Jun NH2-terminal kinase is required for intercellular adhesion molecule-1 expression mediated by interleukin-1β: involvement of sequential activation of tyrosine kinase, nuclear factor-κB-inducing kinase, and IκB kinase 2. Mol Pharmacol 58: 1479-1489, 2000.
5. Cuzzocrea S, McDonald MC, Mazzon E, Mota-Filipe H, Lepore V, Ciccolo A, Terranova ML, Britti D, Caputi AP, and Thiemermann C. The tyrosine kinase inhibitor tyrphostin AG 126 reduced the development of colitis in the rat. Lab Invest 80: 1439-1453, 2000.
6. Cuzzocrea S, McDonald MC, Mazzon E, Siriwardena D, Calabro G, Britti D, Mazzullo G, De Sarro A, Caputi AP, and Thiemermann C. The tyrosine kinase inhibitor tyrphostin AG126 reduces the development of acute and chronic inflammation. Am J Pathol 157: 145-158, 2000.
7. De Vos J, Jourdan M, Tarte K, Jasmin C, and Klein B. JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells. Br J Haematol 109: 823-828, 2000.
8. De Winter BY, Boeckxstaens GE, De Man JG, Moreels TG, Herman AG, and Pelckmans PA. Differential effect of indomethacin and ketorolac on postoperative ileus in rats. Eur J Pharmacol 344: 71-76, 1998.
9. Di Salvo J, Steusloff A, Semenchuk L, Satoh S, Kolquist K, and Pfitzer G. Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle. Biochem Biophys Res Commun 190: 968-974, 1993.
10. Dugo L, Chatterjee PK, Mazzon E, McDonald MC, Paola RD, Fulia F, Caputi AP, Thiemermann C, and Cuzzocrea S. The tyrosine kinase inhibitor tyrphostin AG 126 reduces the multiple organ failure induced by zymosan in the rat. Intensive Care Med 28: 775-788, 2002.
11. Eskandari MK, Kalff JC, Billiar TR, Lee KK, and Bauer AJ. Lipopolysaccharide activates the muscularis macrophage network and suppresses circular smooth muscle activity. Am J Physiol Gastrointest Liver Physiol 273: G727-G734, 1997.
12. Eskandari MK, Kalff JC, Lee KK, and Bauer AJ. Lipopolysaccharide activates jejunal muscularis macrophages and suppresses circular muscularis activity. Transplant Proc 30: 2670, 1998.
13. Graber JN, Schulte WJ, Condon RE, and Cowles VE. Relationship of duration of postoperative ileus to extent and site of operative dissection. Surgery 92: 87-92, 1982.
14. Hierholzer C, Kalff JC, Audolfsson G, Billiar TR, Tweardy DJ, and Bauer AJ. Molecular and functional contractile sequelae of rat intestinal ischemia/reperfusion injury. Transplantation 68: 1244-1254, 1999.
15. a. Hierholzer C, Kalff JC, Chakraborty A, Watkins SC, Billiar TR, Bauer AJ, and Tweardy DJ. Impaired gut contractility following hemorrhagic shock is accompanied by IL-6 and G-CSF production and neutrophil infiltration. Dig Dis Sci 46: 230-241, 2001.
16. Josephs MD, Cheng G, Ksontini R, Moldawer LL, and Hocking MP. Products of cyclooxygenase-2 catalysis regulate postoperative bowel motility. J Surg Res 86: 50-54, 1999.
17. Kalff JC, Buchholz BM, Eskandari MK, Hierholzer C, Schraut WH, Simmons RL, and Bauer AJ. Biphasic response to gut manipulation and temporal correlation of cellular infiltrates and muscle dysfunction in rat. Surgery 126: 498-509, 1999.
18. Kalff JC, Carlos TM, Schraut WH, Billiar TR, Simmons RL, and Bauer AJ. Surgically induced leukocytic infiltrates within the rat intestinal muscularis mediate postoperative ileus. Gastroenterology 117: 378-387, 1999.
19. Kalff JC, Schraut WH, Billiar TR, Simmons RL, and Bauer AJ. Role of inducible nitric oxide synthase in postoperative intestinal smooth muscle dysfunction in rodents. Gastroenterology 118: 316-327, 2002.
20. Kalff JC, Schraut WH, Simmons RL, and Bauer AJ. Surgical manipulation of the gut elicits an intestinal muscularis inflammatory response resulting in postsurgical ileus. Ann Surg 228: 652-663, 1998.
21. Lo CJ, Cryer HG, Fu M, and Lo FR. Regulation of macrophage eicosanoid generation is dependent on nuclear factor κB. J Trauma 45: 19-23, 1998.
22. Lockhart BP, Cressey KC, and Lepagnol JM. Suppression of nitric oxide formation by tyrosine kinase inhibitors in murine N9 microglia. Br J Pharmacol 123: 879-889, 1998.
23. Lopez-Talavera JC, Levitzki A, Martinez M, Gazit A, Esteban R, and Guardia J. Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites. J Clin Invest 100: 664-670, 1997.
24. Matsumoto M, Tanaka T, Kaisho T, Sanjo H, Copeland NG, Gilbert DJ, Jenkins NA, and Akira S. A novel LPS-inducible C-type lectin is a transcriptional target of NF-IL6 in macrophages. J Immunol 163: 50395048, 1999.
25. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T, and Akira S. Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci USA 90: 10193-10197, 1993.
26. Miller MS, Galligan JJ, and Burks TF. Accurate measurement of intestinal transit in the rat. J Pharmacol Methods 6: 211-217, 1981.
27. Moojen TM, Van Gulik TM, Hoek FJ, Gouma DJ, Tytgat GN, and Boeckxstaens GE. Possible role of nitric oxide in postoperative ileus: a comparative study, Neurogastroenterol Motil 11: 403-408, 1999.
28. Novogrodsky A, Vanichkin A, Patya M, Gazit A, Osherov N, and Levitzki A. Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science 264: 1319-1322, 1994.
29. Overbergh L, Valckx D, Waer M, and Mathieu C. Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 11: 305-312, 1999.
30. Pezzone MA, Fraser MO, Van Bibber MM, and de Groat WC. Physiologic evaluation of colonic motility in awake c-kit-deficient mice and immunofluorescence evaluation of colonic interstitial cells of Cajal. In: Neurogastroenterology-from the Basics to the Clinics, edited by Krammer HJ and Singer MV. London: Kluwer Academic, 2000, p. 461-469.
31. Ruetten H and Thiemermann C. Effects of tyrphostins and genistein on the circulatory failure and organ dysfunction caused by endotoxin in the rat: a possible role for protein tyrosine kinase. Br J Pharmacol 122: 59-70, 1997.
32. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, and Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 90: 7240-7244, 1993.
33. Schmittgen TD, Zakrajsek BA, Mills AG, Gorn V, Singer MJ, and Reed MW. Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal Biochem 285: 194-204, 2000.
34. Schwarz NT, Kalff JC, Billiar TR, Schraut WT, and Bauer AJ. Cyclooxygenase-2 mediates a significant component of postoperative ileus (Abstract). Gastroenterology, Suppl 116: A1080, 1999.
35. Schwarz NT, Kalff JC, Türler A, Engel BM, Watkins SC, Billiar TR, and Bauer AJ. Prostanoid production via COX-2 as a causative mechanism of rodent postoperative ileus. Gastroenterology 121: 1354-1371, 2001.
36. Shibata Y, Toyoda S, Nimura Y, and Miyati M. Patterns of intestinal motility recovery during the early stage following abdominal surgery: clinical and manometric study. World J Surg 21: 806-809, 1997.
37. Takehana K, Konishi A, Oonuki A, Noguchi M, Fujita K, Iino Y, and Kobayashi T. APC0576, a novel inhibitor of NF-κB-dependent gene activation, prevents pro-inflammatory cytokine-induced chemokine production in human endothelial cells. Biochem Biophys Res Commun 293: 945-952, 2002.
38. Türler A, Kalff JC, Moore BA, Hoffman RA, Billiar TR, Simmons RL, and Bauer AJ. The inducible nitric oxide synthase (iNOS) gene in leukocyte mediates intestinal dysmotility in murine postoperative ileus (Abstract). Gastroenterology 120: A535, 2001.
39. Türler A, Moore BA, Pezzone MA, Overhaus M, Kalff JC, and Bauer AJ. Colonic postoperative inflammatory ileus in the rat. Ann Surg 236: 56-66, 2002.
40. Türler A, Schwarz NT, Türler E, Kalff JC, and Bauer AJ. MCP-1 causes leukocyte recruitment and subsequently endotoxemic ileus in rat. Am J Physiol Gastrointest Liver Physiol 282: G145-G155, 2002.
41. Waldhausen JH, Shaffrey ME, Skenderis BS, Jones RS, and Schirmer BD. Gastrointestinal myoelectric and clinical patterns of recovery after laparotomy. Ann Surg 211: 777-784, 1990.
42. Wilson JP. Postoperative motility of the large intestine in man. Gut 16: 689-692, 1975.
43. Yang SG, Saifeddine M, and Hollenberg MD. Tyrosine kinase inhibitors and the contractile action of epidermal growth factor-urogastrone and other agonists in gastric smooth muscle. Can J Physiol Pharmacol 70: 85-93, 1992.
44. Zhou D, Yu T, Chen G, Brown SA, Yu Z, Mattson MP, and Thompson JS. Effects of NF-κβ1 (p50) targeted gene disruption on ionizing radiation-induced NF-κB activation and TNFα, 1L-1α-1α, IL-1β and IL-6 mRNA expression in vivo. Int J Radiat Biol 77: 763-772, 2001.